Johnson & Johnson Vision News
Print this Article | Send to Colleague
Johnson & Johnson Vision News
Johnson & Johnson Vision Receives FDA Approval for Next Generation
Monofocal Intraocular Lens
Johnson & Johnson Vision has received FDA approval for the TECNIS Eyhance™ and TECNIS Eyhance™ Toric II intraocular lens (IOL) for the treatment of cataract patients in the United States. The TECNIS Eyhance IOL is the latest lens in the TECNIS Family, which celebrated its 20th anniversary in February.
The TECNIS Family portfolio is the broadest mix of IOLs for cataract patients in need of monofocals, multifocals, extended depth of focus (EDOF), and those with or without astigmatism. Read more on the latest IOL or the 20th anniversary of TECNIS.
